Forte Biosciences (FBRX)

• Market cap: $321M
• 1 day: -5.15%
• 5 days: -18.43%
• 1 month: -34.76%
• 3 months: -44%
• 6 months: -20.62%
• Year to date: -33.63%
• 1 year: 31.13%
• 5 years: -98.52%
• 10 years: -99.66%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Employees: 22